Optimizing workflow for pulse field ablation in atrial fibrillation
Treatments studied
Part of Heart & circulation clinical trials.
This trial tests a better way to perform a procedure called pulse field ablation for people with atrial fibrillation (AF). It aims to make the treatment smoother and safer.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have atrial fibrillation that comes and goes (paroxysmal) or is constant (persistent).
- You are scheduled to have a procedure that isolates the pulmonary veins (PVI).
- You can understand the study and agree to follow its rules for one year.
- You do not have a known allergy to the drug lidocaine.
- You do not have a blood clot in the heart's left atrium or its small pouch.
- You do not have serious lung disease like asthma or COPD that needs daily treatment.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a newer ablation technique called pulsed field ablation to treat atrial fibrillation, a heart rhythm disorder. The goal is to see if this method works well and is safe for patients who need treatment.
This trial tests a new type of heart procedure called pulsed field ablation to treat an irregular heartbeat (atrial fibrillation) in people who have already had a device placed to close off a part of the heart (left atrial appendage occlusion). The goal is to see if this safer ablation method can help control your heart rhythm.
This trial compares a newer type of ablation (pulsed field) with the standard radiofrequency ablation for people with persistent atrial fibrillation that hasn't been treated with ablation before. The goal is to see which method works better and has fewer risks.
This trial tests a new method called pulsed field ablation to treat atrial fibrillation (AF), a type of irregular heartbeat. It aims to safely stop AF episodes by targeting specific areas in the heart, and may help people with paroxysmal (coming and going) or persistent AF who haven't had this procedure before.
This trial tests a new way to treat non-paroxysmal atrial fibrillation (AF) using a focused type of ablation (pulsed-field energy) on specific areas of the heart. It aims to see if targeting the left atrial wall and mitral isthmus can improve outcomes for people who have not had this procedure before.
This trial studies a new procedure called pulsed field ablation to treat brief episodes of atrial fibrillation (AFib). The goal is to see if it can help reset the heart's natural electrical system and reduce symptoms.
Hear when a new Pulsed Field Ablation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.